You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NSC-102816

Showing 1 - 25 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

Recruiting
  • Hodgkin's Lymphoma
  • Houston, Texas
    MD Anderson Cancer Center
Oct 5, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)

Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Colorectal Cancer Trial in Houston (Azacitidine, Capecitabine, Oxaliplatin)

Completed
Has Results
  • Colorectal Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 3, 2020

Leukemia Trial in Houston (Azacitidine (AZA), Tyrosine kinase inhibitor (TKI), Azacitidine)

Completed
  • Leukemia
  • Azacitidine (AZA)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2020

Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

Active, not recruiting
  • Leukemia
  • Azacitidine (AZA) Days 1 - 3
  • +3 more
  • Tampa, Florida
  • +5 more
Jul 21, 2020

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Leukemia Trial in Houston (Lirilumab, Nivolumab, Azacitidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Leukemia Trial in Houston (Azacytidine, Sorafenib)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York

Completed
  • Acute Myeloid Leukemia
  • +7 more
  • Baltimore, Maryland
  • +2 more
Oct 17, 2019

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in Baltimore (Azacitidine Injection, sodium phenylbutyrate)

Completed
  • Lymphoma
  • +2 more
  • Azacitidine Injection
  • sodium phenylbutyrate
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 9, 2019

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Leukemia Trial in Houston (Pacritinib, 5-azacitidine, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Leukemia Trial in Houston (5-azacytidine, PKC412)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Dementia Trial in Málaga (Nordic Sensi Chair)

Completed
  • Dementia
  • Nordic Sensi Chair
  • Málaga, Spain
    Instituto Andaluz de Neurociencia
Jan 30, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)

Recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2021